Cash & equivalents increased 72.2%
Cash & equivalents changed +72.2% from the comparable as-filed period.
$62.1M→$107.0M2 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +72.2% from the comparable as-filed period.
Operating income changed -28.8% from the comparable as-filed period.
Net income changed -40.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.